Results 101 to 110 of about 578 (168)

The use of adjunctive therapies during oral immunotherapy: A focus on biologics. [PDF]

J Food Allergy, 2022
Albuhairi S, Rachid R.
europepmc   +1 more source

040 Updosing of non sedating antihistamines can improve the treatment of patients with cholinergic urticaria [PDF]

Journal of Investigative Dermatology, 2016
S. Altrichter, K. Wosny, K. Weller, A. Werner, M. Maurer   +4 more
openaire   +1 more source

ADP101 multifood oral immunotherapy for food-allergic patients: Harmony phase 1/2 randomized clinical trial. [PDF]

J Allergy Clin Immunol Glob
Kim EH, Carr WW, Assa'ad AH, Gogate SU, Petroni DH, Casale TB, Wang ML, Sullivan A, Archer AM, Wang O, Piscia-Nichols C, Tuomi L, Levin-Young O, Dombkowski A, McClintock D, Harmony investigators.   +15 more
europepmc   +1 more source

Oral Immunotherapy in Peanut-Allergic Adults Using Real-World Materials. [PDF]

Allergy
Hunter H, Ue KL, Cornelius V, Yung CC, Thomas I, Tsilochristou O, Layhadi J, Siew LQC, Venter C, Shamji MH, Till SJ.   +10 more
europepmc   +1 more source

Tolerance of the venom immunotherapy switch from a highly purified aluminium hydroxide adsorbed hymenoptera venom extract to a nonpurified aqueous venom extract. [PDF]

World Allergy Organ J
Gschwend A, Joerg L.
europepmc   +1 more source

Early Changes in House Dust Mite Component Specific Immunoglobulin Levels Predict the One-Year Efficacy of Allergen Immunotherapy in Patients With Allergic Rhinitis. [PDF]

Clin Transl Allergy
Li S, Ma Y, Li J, Feng X, Xiong F, Han M, Li H, Lou H.   +7 more
europepmc   +1 more source

Navigating Non-Response: Prognosis and Strategies in Chronic Spontaneous Urticaria Management. [PDF]

Int J Dermatol
Kocatürk E, Zuberbier T.
europepmc   +1 more source

Optimizing Psoriasis Treatment with Tildrakizumab: Current Evidence and Expert Recommendations for Treatment Individualization in Clinical Practice. [PDF]

Dermatol Ther (Heidelb)
Ruiz-Villaverde R, Mateu A, Mendes-Bastos P, Torres T.   +3 more
europepmc   +1 more source

Advancements and challenges in the management of chronic inducible urticaria. [PDF]

Front Immunol
Zhang M, Liu J, Zhi Y.
europepmc   +1 more source

Predictors of treatment control in severe chronic urticaria treated with omalizumab. [PDF]

Asia Pac Allergy
Proença M, Marcelino J, Vieira J, Guimarães J, Dias C, Tomaz E.   +5 more
europepmc   +1 more source